Details
Title
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
Author
Liu, Dan 1 ; Xu Zefeng 1 ; Zhang, Peihong 2 ; Qin Tiejun 1 ; Li, Bing 1 ; Qu Shiqiang 1 ; Pan Lijuan 1 ; Cai Wenyu 2
; Liu Jinqin 3 ; Wang, Huijun 2 ; Sun, Qi 2 ; Sun, Xiujuan 3 ; Jiao Meng 1 ; Gao Qingyan 1 ; Shi Zhongxun 1 ; Huang, Huijun 1 ; Huang, Gang 4
; Gale, Robert Peter 5 ; Xiao Zhijian 6
1 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
2 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, Hematologic Pathology Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
3 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
4 Cincinnati Childrens Hospital Medical Center, Divisions of Experimental Hematology and Cancer Biology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
5 Imperial College London, Haematology Research Centre, Department of Immunology and Inflammation, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
6 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, Hematologic Pathology Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
; Liu Jinqin 3 ; Wang, Huijun 2 ; Sun, Qi 2 ; Sun, Xiujuan 3 ; Jiao Meng 1 ; Gao Qingyan 1 ; Shi Zhongxun 1 ; Huang, Huijun 1 ; Huang, Gang 4
; Gale, Robert Peter 5 ; Xiao Zhijian 6
1 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
2 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, Hematologic Pathology Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
3 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
4 Cincinnati Childrens Hospital Medical Center, Divisions of Experimental Hematology and Cancer Biology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
5 Imperial College London, Haematology Research Centre, Department of Immunology and Inflammation, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
6 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Chinese Academy of Medical Sciences & Peking Union Medical College, Hematologic Pathology Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
Publication year
2021
Publication date
Sep 2021
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2573632043
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.